Soybean Peptide Lunasin Suppresses In Vitro and In Vivo 7,12-Dimethylbenz[a]anthracene-Induced Tumorigenesis

Journal of Food Science

Volumn 75, Issue 9, 2010, Pages

  Hsieh, Chia Chien ^a   Hernández Ledesma, Blanca ^a   De Lumen, Ben O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

12 dimethylbenz(a)anthracene; 3 methylcholanthrene; 7; Cancer preventive properties; Lunasin; Mammary cancer; Soy protein

Indexed keywords

3 METHYLCHOLANTHRENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CARCINOGEN; GM2S 1 PROTEIN, GLYCINE MAX; GM2S-1 PROTEIN, GLYCINE MAX; PEPTIDE; SOYBEAN PROTEIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FEMALE; MOUSE; PROTEIN INTAKE; SENSITIVE TO CARCINOGENESIS MOUSE; SOYBEAN;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOGENS; CELL PROLIFERATION; DIETARY PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED SENCAR; NEOPLASMS, EXPERIMENTAL; NIH 3T3 CELLS; PEPTIDES; SOYBEAN PROTEINS; SOYBEANS;

GLYCINE MAX; MUS;

EID: 78149379509     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2010.01861.x     Document Type: Article

References (31)

1. Adlercreutz CH, Goldin BR, Gorbach SL, Höckerstedt KA, Watanabe S, Hämäläinen EK, Markkanen MH, Mäkelä TH, Wähälä KT, Adlercreutz T. 1995. Soybean phytoestrogen intake and cancer risk. J Nutr 25:757S-70S.
2. Banerjee S, Li Y, Wang Z, Sarkar FH. 2008. Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226-42.
3. Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, McTiernan A, Offit K, Perlman JA, Petersen G, Thomson E. 1997. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA J Am Med Assoc 277:997-1003.
4. Currier N, Solomon SE, Demicco EG, Chang DLF, Farago M, Ying HQ, Dominguez I, Soneshein GE, Cardiff RD, Xiao ZXJ, Sherr DH, Seldin DC. 2005. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Tox Pathol 33:726-37.
5. Dia VP, Torres S, De Lumen BO, Erdman Jr JW, De Mejia G. 2009. Presence of lunasin in plasma of men alter soy protein consumption. J Agric Food Chem 57:1260-6.
6. Fischer SM, Conti CJ, Locniskar M, Belury MA, Maldve RE, Lee ML, Leyton J, Slaga TJ, Betchel DH. 1992. The effect of dietary fat on the rapid development of mammary tumor induced by 7, 12-dimethylbenz[a]anthracene in Sencar mice. Cancer Res 52:662-6.
7. Galvez AF, Chen N, Macasieb J, De Lumen BO. 2001. Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61:7473-8.
8. Hakkak R, Korourian S, Ronis M, Shelnutt S, Lensing S, Sweeny J, Irby D, Weatherford C, Badger T. 1999. Dietary whey or soy prevents DMBA-induced mammary cancer in rats: effects of diets fed over two generations. FASEB J 13:A583.
9. Hecht SS. 2002. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 39:119-26.
10. Hernández-Ledesma B, Hsieh C-C, De Lumen BO. 2009a. Lunasin: a novel seed peptide for cancer prevention. Peptides 30:426-30.
11. Hernández-Ledesma B, Hsieh C-C, De Lumen BO. 2009b. Lunasin and Bowman-Birk protease inhibitor (BBI) in us commercial soy foods. Food Chem 115:574-80.
12. Hortobagyi GN, De La Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu M-C, Martin M, Namer M, O'Shaughnessy JA, Shen ZZ, Albain KS. 2005. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391-401.
13. Jeong HJ, Park JH, Lam Y, De Lumen BO. 2003. Characterization of lunasin isolated from soybean. J Agric Food Chem 51:7901-6.
14. Jeong HJ, Jeong JB, Kim DS, De Lumen BO. 2007. Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem 55:632-7.
15. Kennedy AR. 1998. Chemopreventive agents: protease inhibitors. Pharmacol Ther 78:167-209.
16. Kim HA, Jeong KS, Kim YK. 2008. Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res 28:2837-41.
17. Lam Y, Galvez A, De Lumen BO. 2003. Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr Cancer 47:88-94.
18. Lin C-C, Lu Y-P, Lou Y-R, Ho C-T, Newmark HH, MacDonald C, Singletary KW, Huang MT. 2001. Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett 168:125-32.
19. Losso JN. 2008. The biochemical and functional food properties of the Bowman-Birk Inhibitor. Crit Rev Food Sci Nutr 48:94-118.
20. Messina M, Barnes S. 1991. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83:541-6.
21. Messina M, Wu AH. 2009. Perspectives on the soy-breast cancer relation. Am J Clin Nutr 89:1673S-9S.
22. Messina MJ, Persky V, Setchell KDR, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:113-31.
23. Mukhopadhyay S, Ballard BR, Mukherjee S, Kabir SM, Das SK. 2006. Beneficial effects of soy protein in the initiation and progression against dimethylbenz[a]anthacene-induced breast tumors in female rats. Mol Cell Biochem 290:169-76.
24. Park JH, Jeong HJ, De Lumen BO. 2007. In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J Agric Food Chem 55:10703-6.
25. Park K, Choi K, Kim H, Kim K, Lee MH, Lee JH, Rim JCK. 2009. Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis. Exp Mol Med 41:371-80.
26. Prince M, Campbell CT, Robertson TA, Wells AJ, Kleiner HE. 2006. Naturally occurring coumarins inhibit 7, 12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland. Carcinogenesis 27:1204-13.
27. Qing W-G, Conti CJ, LaBate M, Johnston D, Slaga TJ, McCleod MC. 1997. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7, 12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 18:553-9.
28. Ramar PS, Ponnampalam G, Savarimuthu I. 2006. Anti-tumor promoting potential of luteolin against 7, 12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Chem Biol Inter 164:1-14.
29. Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao WF, Grumet S, Perera FP. 2000. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21:1281-9.
30. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW, Kelloff GJ. 1994. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl 20:32-54.
31. Weyandt J, Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL. 2008. Environmental chemicals and breast cancer risk: a structural chemistry perspective. Curr Med Chem 15:2680-701.